Maybe not immediately, according to a release issued by the company, but eventually and probably soon, if they aren't purchased by another operator
Affordability is the top reason users would consider switching from semaglutide to liraglutide (65%)
There is growing interest in compounded GLP-1 medications as a more affordable alternative, but these drugs are under increased scrutiny due to safety concerns and questions over how they are marketed
when additional pharmacotherapy is needed, selection should be guided by liver disease severity, pain type and comorbidity profile, with close monitoring for adverse effects
COMMUNITY SPOTLIGHT Community Content Share with me content that youve written and Ill post it here
Because they havent undergone the FDAs strict testing for safety and efficacy, theres no way to know if they work or what health risks they might pose